Del Mar, CA, United States of America

Daljit Singh Dhanoa

USPTO Granted Patents = 20 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 79(Granted Patents)


Location History:

  • Wakefield, MA (US) (2009)
  • West Chester, PA (US) (2001 - 2010)
  • Del Mar, CA (US) (2003 - 2023)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
20 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Daljit Singh Dhanoa**

Introduction

Daljit Singh Dhanoa, a prominent inventor based in Del Mar, CA, has made significant contributions to the field of pharmaceutical innovations. With a noteworthy portfolio of 19 patents, his work primarily focuses on the development of novel compounds aimed at addressing critical health issues, including infectious respiratory diseases and cognitive impairments.

Latest Patents

Among his latest breakthroughs are two significant patents. The first patent pertains to deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitors. This invention encompasses novel compounds that inhibit ACE-2, displaying high potency and selectivity. These compounds are indicated for the treatment of various infectious respiratory diseases, including the pandemic disease Covid-19, as well as SARS-CoV-2 and SARS-CoV.

The second patent involves deuterium-enriched pyridinonecarboxamides and their derivatives. These compounds act as partial or full agonists of the serotonin receptor subtype 4 (5-HT4) and hold therapeutic potential for a wide range of conditions, such as Alzheimer's disease, cognitive dysfunction, and various gastrointestinal disorders. Their applications range from aiding cognitive function and memory improvement to addressing complex psychological conditions, reflecting the versatility and need for innovative solutions in modern medicine.

Career Highlights

Daljit Singh Dhanoa's career is marked by a dedication to research and innovation in the pharmaceutical sector. He has collaborated with notable companies, continuing to expand his expertise and impact in the field. His contributions through patent development represent a blend of scientific ingenuity and practical application in healthcare.

Collaborations

Throughout his career, Dhanoa has worked alongside esteemed colleagues, including Richard M. Soll and Dario Doller. These collaborations have further enriched his work, creating a synergy that has led to the development of innovative solutions to pressing medical challenges.

Conclusion

In summary, Daljit Singh Dhanoa's innovative work and prolific patent portfolio underscore his status as a key contributor to pharmaceuticals. His commitment to advancing research and addressing pervasive health issues continues to inspire further exploration and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…